They have exceeded their targets for FY14. They have advised they are on track to deliver their FY15 target of $26m NPAT.
Quote from this media release:
"Based on current forecasts and information, Monash IVF Group is on track to deliver on its
FY15 forecasts as outlined in the Prospectus of June 2014."
Current PE is ~79. Forward FY15 is ~14.7 if they hit their target of $26m NPAT. Need to remember that the IPO costs incurred in FY14 will not be there in FY15. Large institutions are on the share register. The current price of $1.65 is ~10% discount to the IPO price of $1.85. This is a strong buy IMPO at this price.
DYOR
Ann: Monash IVF 2014 Financial results media release, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
75.0¢ |
Change
-0.010(1.32%) |
Mkt cap ! $292.2M | |||
| Open | High | Low | Value | Volume |
| 76.0¢ | 76.5¢ | 75.0¢ | $1.443M | 1.911M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 165572 | 75.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 75.5¢ | 719 | 1 |
View Market Depth
| Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
| MVF (ASX) Chart |